A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hypertrophic Cardiomyopathy
Interventions
DIAGNOSTIC_TEST

12-Lead ECG

A clinically performed 12-lead ECG tracing within 30 days of the appointment will be obtained from the subject medical record and will be used for AI-ECG analyses.

DIAGNOSTIC_TEST

Apple Smart Watch Single Lead ECG

A single lead ECG tracing will be collected using an Apple Smart Watch and tracing will be used for AI-ECG analyses.

DIAGNOSTIC_TEST

AliveCor KardiaMobile 6-Lead ECG

A 6-lead ECG tracing will be collected using an AliveCor KardiaMobile device and tracing will be used for AI-ECG analyses.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER